Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Q4 2018 Axonics Modulation Technologies Inc Earnings Call Transcript

Mar 05, 2019 / 09:30PM GMT
Release Date Price: $20.75 (-3.22%)
Operator

Good day, ladies and gentlemen, and welcome to the Axonics Fourth Quarter and Year-End 2018 Results Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.

I would now like to introduce your host for today's conference, Mr. Matt Clawson from W2O Group. Sir, you may begin.

Matthew Clawson
Pure Communications, Inc. - Senior VP and MD of the IR & Financial Communications Practice

Thank you very much, and thanks, everyone, for joining the Axonics quarterly results and update call. Joining me on the call from Axonics this afternoon are Ray Cohen, Chief Executive Officer; Dan Dearen, President and Chief Financial Officer; and Karen Noblett, M.D., Chief Medical Officer. Ray and Dan will provide prepared remarks and commentary on the fourth quarter financial results and business update. And Dr. Noblett will provide details on the ARTISAN-SNM clinical study, followed by a Q&A session.

Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot